These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome. Angelini R; Russo S; Corcelli A; Lobasso S J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404345 [TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice. Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945 [TBL] [Abstract][Full Text] [Related]
24. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome. Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974 [TBL] [Abstract][Full Text] [Related]
25. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures. Liu O; Chinni BK; Manlhiot C; Vernon HJ Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445 [TBL] [Abstract][Full Text] [Related]
26. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Barth PG; Valianpour F; Bowen VM; Lam J; Duran M; Vaz FM; Wanders RJ Am J Med Genet A; 2004 May; 126A(4):349-54. PubMed ID: 15098233 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1. Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168 [TBL] [Abstract][Full Text] [Related]
28. Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV. Corey RA; Harrison N; Stansfeld PJ; Sansom MSP; Duncan AL Chem Sci; 2022 Nov; 13(45):13489-13498. PubMed ID: 36507170 [TBL] [Abstract][Full Text] [Related]
29. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function. Ye C; Shen Z; Greenberg ML J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572 [TBL] [Abstract][Full Text] [Related]
30. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease. Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286 [TBL] [Abstract][Full Text] [Related]
31. Interplay between cardiolipin and plasmalogens in Barth syndrome. Bozelli JC; Epand RM J Inherit Metab Dis; 2022 Jan; 45(1):99-110. PubMed ID: 34655242 [TBL] [Abstract][Full Text] [Related]
32. Seven functional classes of Barth syndrome mutation. Whited K; Baile MG; Currier P; Claypool SM Hum Mol Genet; 2013 Feb; 22(3):483-92. PubMed ID: 23100323 [TBL] [Abstract][Full Text] [Related]
33. Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome. Angelini R; Lobasso S; Gorgoglione R; Bowron A; Steward CG; Corcelli A J Lipid Res; 2015 Sep; 56(9):1787-94. PubMed ID: 26144817 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis. Danos M; Taylor WA; Hatch GM Biochem Cell Biol; 2008 Feb; 86(1):11-20. PubMed ID: 18364741 [TBL] [Abstract][Full Text] [Related]
35. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation. Taylor WA; Mejia EM; Mitchell RW; Choy PC; Sparagna GC; Hatch GM PLoS One; 2012; 7(11):e48628. PubMed ID: 23152787 [TBL] [Abstract][Full Text] [Related]
37. Cellular functions of cardiolipin in yeast. Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250 [TBL] [Abstract][Full Text] [Related]
38. Tafazzin splice variants and mutations in Barth syndrome. Kirwin SM; Manolakos A; Barnett SS; Gonzalez IL Mol Genet Metab; 2014 Jan; 111(1):26-32. PubMed ID: 24342716 [TBL] [Abstract][Full Text] [Related]
39. Molecular Dynamics Analysis of Cardiolipin and Monolysocardiolipin on Bilayer Properties. Boyd KJ; Alder NN; May ER Biophys J; 2018 May; 114(9):2116-2127. PubMed ID: 29742405 [TBL] [Abstract][Full Text] [Related]
40. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome. Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]